US Stock MarketDetailed Quotes

LTRN Lantern Pharma

Watchlist
  • 4.620
  • +0.210+4.76%
Close Jul 22 16:00 ET
  • 4.500
  • -0.120-2.60%
Post 17:31 ET
49.71MMarket Cap-2851P/E (TTM)

Lantern Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
33.73%5.73M
23.87%17.88M
27.47%4.88M
64.25%3.52M
18.10%5.19M
5.41%4.29M
14.62%14.43M
8.97%3.83M
-48.29%2.15M
77.28%4.39M
Selling and administrative expenses
-14.54%1.48M
2.63%5.98M
-17.18%1.3M
-8.96%1.31M
16.08%1.63M
23.27%1.73M
16.11%5.83M
16.73%1.57M
21.82%1.44M
6.99%1.41M
-General and administrative expense
-14.54%1.48M
2.63%5.98M
-17.18%1.3M
-8.96%1.31M
16.08%1.63M
23.27%1.73M
16.11%5.83M
16.73%1.57M
21.82%1.44M
6.99%1.41M
Research and development costs
66.51%4.25M
38.26%11.89M
58.70%3.57M
214.67%2.21M
19.05%3.56M
-4.03%2.55M
13.64%8.6M
4.13%2.25M
-76.31%702.3K
156.58%2.99M
Operating profit
-33.73%-5.73M
-23.87%-17.88M
-27.47%-4.88M
-64.25%-3.52M
-18.10%-5.19M
-5.41%-4.29M
-14.62%-14.43M
-8.97%-3.83M
48.29%-2.15M
-77.28%-4.39M
Net non-operating interest income expense
50.21%200.95K
274.54%765.39K
258.03%267.39K
371.80%246.39K
114.12%117.82K
496.68%133.78K
200.84%204.36K
230.61%74.68K
-32.37%52.22K
14.90%55.03K
Non-operating interest income
50.21%200.95K
274.54%765.39K
258.03%267.39K
371.80%246.39K
114.12%117.82K
496.68%133.78K
200.84%204.36K
230.61%74.68K
-32.37%52.22K
14.90%55.03K
Other net income (expense)
-68.31%90.24K
3,747.29%1.15M
14.46%424.07K
167.45%115.78K
313.69%326.08K
465.97%284.72K
-119.65%-31.55K
1,216.22%370.49K
-1,070.91%-171.65K
-233.01%-152.59K
Other non- operating income (expenses)
-68.31%90.24K
3,747.29%1.15M
14.46%424.07K
167.45%115.78K
313.69%326.08K
465.97%284.72K
-119.65%-31.55K
1,216.22%370.49K
-1,070.91%-171.65K
-233.01%-152.59K
Income before tax
-40.67%-5.44M
-11.93%-15.96M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
-15.34%-14.26M
4.50%-3.38M
44.14%-2.26M
-93.93%-4.49M
Income tax
Net income
-40.67%-5.44M
-11.93%-15.96M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
-15.34%-14.26M
4.50%-3.38M
44.14%-2.26M
-93.93%-4.49M
Net income continuous Operations
-40.67%-5.44M
-11.93%-15.96M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
-15.34%-14.26M
4.50%-3.38M
44.14%-2.26M
-93.93%-4.49M
Minority interest income
Net income attributable to the parent company
-40.67%-5.44M
-11.93%-15.96M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
-15.34%-14.26M
4.50%-3.38M
44.14%-2.26M
-93.93%-4.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-40.67%-5.44M
-11.93%-15.96M
-23.80%-4.19M
-39.60%-3.16M
-5.65%-4.75M
6.16%-3.87M
-15.34%-14.26M
4.50%-3.38M
44.14%-2.26M
-93.93%-4.49M
Basic earnings per share
-41.67%-0.51
-12.21%-1.47
-25.81%-0.39
-38.10%-0.29
-7.32%-0.44
5.26%-0.36
-15.93%-1.31
0.00%-0.31
41.67%-0.21
-95.24%-0.41
Diluted earnings per share
-41.67%-0.51
-12.21%-1.47
-25.81%-0.39
-38.10%-0.29
-7.32%-0.44
5.26%-0.36
-15.93%-1.31
2.90%-0.31
41.67%-0.21
-95.24%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 33.73%5.73M23.87%17.88M27.47%4.88M64.25%3.52M18.10%5.19M5.41%4.29M14.62%14.43M8.97%3.83M-48.29%2.15M77.28%4.39M
Selling and administrative expenses -14.54%1.48M2.63%5.98M-17.18%1.3M-8.96%1.31M16.08%1.63M23.27%1.73M16.11%5.83M16.73%1.57M21.82%1.44M6.99%1.41M
-General and administrative expense -14.54%1.48M2.63%5.98M-17.18%1.3M-8.96%1.31M16.08%1.63M23.27%1.73M16.11%5.83M16.73%1.57M21.82%1.44M6.99%1.41M
Research and development costs 66.51%4.25M38.26%11.89M58.70%3.57M214.67%2.21M19.05%3.56M-4.03%2.55M13.64%8.6M4.13%2.25M-76.31%702.3K156.58%2.99M
Operating profit -33.73%-5.73M-23.87%-17.88M-27.47%-4.88M-64.25%-3.52M-18.10%-5.19M-5.41%-4.29M-14.62%-14.43M-8.97%-3.83M48.29%-2.15M-77.28%-4.39M
Net non-operating interest income expense 50.21%200.95K274.54%765.39K258.03%267.39K371.80%246.39K114.12%117.82K496.68%133.78K200.84%204.36K230.61%74.68K-32.37%52.22K14.90%55.03K
Non-operating interest income 50.21%200.95K274.54%765.39K258.03%267.39K371.80%246.39K114.12%117.82K496.68%133.78K200.84%204.36K230.61%74.68K-32.37%52.22K14.90%55.03K
Other net income (expense) -68.31%90.24K3,747.29%1.15M14.46%424.07K167.45%115.78K313.69%326.08K465.97%284.72K-119.65%-31.55K1,216.22%370.49K-1,070.91%-171.65K-233.01%-152.59K
Other non- operating income (expenses) -68.31%90.24K3,747.29%1.15M14.46%424.07K167.45%115.78K313.69%326.08K465.97%284.72K-119.65%-31.55K1,216.22%370.49K-1,070.91%-171.65K-233.01%-152.59K
Income before tax -40.67%-5.44M-11.93%-15.96M-23.80%-4.19M-39.60%-3.16M-5.65%-4.75M6.16%-3.87M-15.34%-14.26M4.50%-3.38M44.14%-2.26M-93.93%-4.49M
Income tax
Net income -40.67%-5.44M-11.93%-15.96M-23.80%-4.19M-39.60%-3.16M-5.65%-4.75M6.16%-3.87M-15.34%-14.26M4.50%-3.38M44.14%-2.26M-93.93%-4.49M
Net income continuous Operations -40.67%-5.44M-11.93%-15.96M-23.80%-4.19M-39.60%-3.16M-5.65%-4.75M6.16%-3.87M-15.34%-14.26M4.50%-3.38M44.14%-2.26M-93.93%-4.49M
Minority interest income
Net income attributable to the parent company -40.67%-5.44M-11.93%-15.96M-23.80%-4.19M-39.60%-3.16M-5.65%-4.75M6.16%-3.87M-15.34%-14.26M4.50%-3.38M44.14%-2.26M-93.93%-4.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -40.67%-5.44M-11.93%-15.96M-23.80%-4.19M-39.60%-3.16M-5.65%-4.75M6.16%-3.87M-15.34%-14.26M4.50%-3.38M44.14%-2.26M-93.93%-4.49M
Basic earnings per share -41.67%-0.51-12.21%-1.47-25.81%-0.39-38.10%-0.29-7.32%-0.445.26%-0.36-15.93%-1.310.00%-0.3141.67%-0.21-95.24%-0.41
Diluted earnings per share -41.67%-0.51-12.21%-1.47-25.81%-0.39-38.10%-0.29-7.32%-0.445.26%-0.36-15.93%-1.312.90%-0.3141.67%-0.21-95.24%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg